Researchers have developed a new blood test to predict the early onset of preeclampsia - a multi-system disorder that affects women in pregnancy. The test which determines the ratio of sFlt-1 to PlGF -- two placental proteins -- can be used to predict whether a pregnant woman will develop preeclampsia or the typical complications associated with it, the researchers said. The researchers were able to determine a cutoff value for the ratio of serum sFlt-1 to PlGF, which allows them to reliably rule out the condition within oNew blood test to predict risk of the preeclampsiane week.
"The ratio of serum sFlt-1 to PlGF can help us to better predict the risk of disease onset or its progression," emphasised the study's corresponding author Stefan Verlohren from Charite - University Medicine Berlin, Germany. The findings of the new study may help in avoiding preterm deliveries and delays in…
